APHSS Doctors Identify Syphilis Test with 14-Day Window Period
APHSS testing facilities can start new testing protocol immediately, alleviating need for performer syphilis treatment
After continued and exhaustive research, APHSS doctors have discovered a new test for syphilis – Treponemal EIA. This state-of-the-art test significantly shortens the window for syphilis testing from 90 days to 14 days.
Trep-Sure is the brand name of the Treponemal EIA test for syphilis that will be utilized by APHSS.org doctors. This test, manufactured by Phoenix Bio-tech Corporation, is FDA approved as a confirmatory diagnostic test for syphilis and has 99-100% levels of sensitivity and specificity.
This discovery provides the industry with a viable alternative to preventative treatment. For performers who have had preventative treatment administered, they will still be available to work 10 days after the date treatment was administered. For performers who have not had the treatment, the waiting time to begin performing has just been reduced from 90 days to 14 days. Because of this significantly shortened window, APHSS is suspending preventative treatment and is asking performers who have not been preventatively treated to go to any APHSS provider and get tested with the new test and to get re-tested 14 days later.
Effective immediately, all APHSS providers will utilize the new Treponemal EIA test in monthly performer testing panel.
For performers who have been preventatively treated with antibiotics:
Performers who have already received a preventative shot or prescription are clear to work, with a clean panel, 10 days after receiving treatment. That means performers who received preventative treatment on August 22, the first day treatment was provided, will be able to perform with a clean panel—that includes the new Treponemal EIA test–on September 1st. If they were treated on August 23rd, they will be available on September 2nd and so on. Performers will be shown as available to work on the APHSS database 10 days after treatment with a clean panel that includes the new Treponemal EIA test for syphilis.
For performers who have not been preventatively treated:
Performers, who have not received preventative antibiotics, should go to any APHSS provider and take the new Treponemal EIA test. If the test is positive, immediate treatment is available. If the test is negative, the performer should wait 14 days and retest with the new Treponemal EIA. With two negative Treponemal EIA tests 14 days apart, along with a cleared panel, the performer will be cleared for work. Performers will be shown as available to work 14 days after a negative Treponemal EIA test with a clean panel that includes the new Treponemal test for syphilis.
“This is great news for the industry,” said Diane Duke FSC Executive Director. “Not only will we be able to use this test to confirm that performers are not infected and can work in a much shorter period of time, but also we will be able to identify those who may have an acute (recent) infection not recognized by the standard RPR syphilis test. Our program has and will continue to seek out the best and latest testing and technologies for the health and well-being of our performers.”
APHSS has thousands of sites for performers to choose from nationwide.
Performers can contact any of the providers below to obtain the new Treponemal EIA test.
AMTC Advanced Medical Testing Center
Locations Nationwide, including California
Cutting Edge Testing – Van Nuys, CA Location
Dr. Peter Miao MD
5000 Van Nuys Blvd. Suite 202, Sherman Oaks, CA 91403
Hours: 10:00am to 5pm Mon–Fri
Cutting Edge Testing – Ft. Lauderdale, FL Location
2312 Wilton Dr.
Wilton Manners, FL 33305
Approximately 2,000 locations nationwide including many in LA and Miami
Hours will vary by location
Dr. Sean Darcy
Concierge physician available to administer tests inLos Angeles, San Diego and San Francisco to groups on site by appt.
To sign up for the APHSS database go to APHSS.org. For any additional questions contact Joanne at 818-348-9373 or firstname.lastname@example.org.